Status:
COMPLETED
Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study
Lead Sponsor:
Vivoxid Ltd
Conditions:
Depressed Lateral Condyle Fracture
Benign Bone Tumour Cavity
Eligibility:
All Genders
Brief Summary
The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.
Eligibility Criteria
Inclusion
- Written informed consent obtained; Participation of previous clinical investigation with bioactive glass
Exclusion
- The subject is unlikely to adhere to study procedures
- Concurrent disease or condition that in the opinion of the investigator is contraindicating participation
- Simultaneous participation in another medical device or investigational drug trial
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00935870
Start Date
January 1 2008
End Date
February 1 2009
Last Update
July 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital
Turku, Finland, FI-20521